ATE547709T1 - Tumorinvasionsfördernde peptidsequenz - Google Patents

Tumorinvasionsfördernde peptidsequenz

Info

Publication number
ATE547709T1
ATE547709T1 AT06837610T AT06837610T ATE547709T1 AT E547709 T1 ATE547709 T1 AT E547709T1 AT 06837610 T AT06837610 T AT 06837610T AT 06837610 T AT06837610 T AT 06837610T AT E547709 T1 ATE547709 T1 AT E547709T1
Authority
AT
Austria
Prior art keywords
opn
growth
patient
expression
peptide sequence
Prior art date
Application number
AT06837610T
Other languages
English (en)
Inventor
F Weber Georg
Original Assignee
Metamol Theranostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metamol Theranostics Llc filed Critical Metamol Theranostics Llc
Application granted granted Critical
Publication of ATE547709T1 publication Critical patent/ATE547709T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06837610T 2005-11-14 2006-11-14 Tumorinvasionsfördernde peptidsequenz ATE547709T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73619305P 2005-11-14 2005-11-14
PCT/US2006/044257 WO2007059166A2 (en) 2005-11-14 2006-11-14 Peptide sequence that promotes tumor invasion

Publications (1)

Publication Number Publication Date
ATE547709T1 true ATE547709T1 (de) 2012-03-15

Family

ID=38049253

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06837610T ATE547709T1 (de) 2005-11-14 2006-11-14 Tumorinvasionsfördernde peptidsequenz

Country Status (4)

Country Link
US (2) US7807790B2 (de)
EP (2) EP1949109B1 (de)
AT (1) ATE547709T1 (de)
WO (1) WO2007059166A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101293924A (zh) * 2007-04-24 2008-10-29 上海国健生物技术研究院 骨桥蛋白的功能表位、与其特异性结合的单克隆抗体及其在制备抗肿瘤转移药物中的用途
US9587278B2 (en) * 2010-01-08 2017-03-07 Oxford Gene Technology (Operations) Ltd. Combined CGH and allele specific hybridisation method
WO2019051041A1 (en) * 2017-09-06 2019-03-14 University Of Cincinnati EARLY PROGNOSTIC METHODS OF MAMMARY LESIONS
CN109705221B (zh) * 2018-12-27 2021-03-09 美康生物科技股份有限公司 C肽免疫原及其单克隆抗体对及该抗体对在c肽磁微粒化学发光免疫试剂中的应用
US20230203193A1 (en) * 2020-06-03 2023-06-29 Georg F. Weber Isolated antibodies and fragments thereof with specificity for osteopontin-c
EP4244392A1 (de) * 2020-11-16 2023-09-20 Inserm (Institut National De La Sante Et De La Recherche Medicale) Verfahren und zusammensetzungen zur vorhersage und behandlung von uvealem melanom

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
JPS63501765A (ja) 1985-11-01 1988-07-21 インタ−ナショナル、ジェネティック、エンジニアリング　インコ−ポレ−テッド 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
CA1319101C (en) 1986-09-03 1993-06-15 Marta Iris Sabara Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP1541682A3 (de) 1988-09-02 2005-07-06 Dyax Corp. Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
JPH06508511A (ja) 1990-07-10 1994-09-29 ケンブリッジ　アンティボディー　テクノロジー　リミティド 特異的な結合ペアーの構成員の製造方法
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
DE69233769D1 (de) 1991-03-01 2009-09-24 Dyax Corp Chimäres Protein mit Mikroprotein mit zwei oder mehr Disulfidbindungen und Ausgestaltungen davon
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
AU2002258518A1 (en) * 2001-03-14 2002-09-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
WO2002101075A2 (en) 2001-06-13 2002-12-19 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
AU2002322280A1 (en) 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20040142865A1 (en) * 2002-10-02 2004-07-22 Weber Georg F. Osteopontin-based cancer therapies
IT1395574B1 (it) 2009-09-14 2012-10-16 Guala Dispensing Spa Dispositivo di erogazione

Also Published As

Publication number Publication date
EP1949109B1 (de) 2012-02-29
EP1949109A4 (de) 2008-12-03
US8969020B2 (en) 2015-03-03
EP2365334A1 (de) 2011-09-14
US20110033857A1 (en) 2011-02-10
WO2007059166A2 (en) 2007-05-24
US7807790B2 (en) 2010-10-05
EP1949109A2 (de) 2008-07-30
WO2007059166A3 (en) 2007-07-26
US20090061436A1 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
DE60006100D1 (de) Lang wirkende insulinotrope peptide
BG108492A (bg) Използване на въглероден окис за подобряване на резултатите при трансплантация на тъкани и органи и потискане на апоптозата
IL180725A0 (en) Inhibitors of angiopoietin-like 4 protein, combinations, and their use
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
BR0214840A (pt) Genes
NO20030856D0 (no) Membranpenetrerende peptider og anvendelse av disse
WO2008083326A3 (en) Targeting of ews-fli1 as anti-tumor therapy
NO20064794L (no) Anvendelse av anti-alfa5beta1-antistoffer for inhibering av kreftcelleproliferasjon
ATE424461T1 (de) Modifizierte zytokine für krebs therapie
ATE547709T1 (de) Tumorinvasionsfördernde peptidsequenz
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
DE60032784D1 (de) Markerproteine für prostatakrebs
PT1147088E (pt) 6-arilfenantridinas com actividade inibitoria da pde-iv
TR200103457T2 (tr) 4-Fenil-Pirimidin Türevleri.
ATE427746T1 (de) 5-methylindirubin zur verwendung in der behandlung von menschlichen festen tumoren
ATE295352T1 (de) Phenanthridine-n-oxide mit pde-iv hemmender wirkung
ATE414100T1 (de) Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
TW200501998A (en) Labeling peptide for nasopharyngeal carcinoma (NPC) cells
ATE431742T1 (de) Modifizierte zytokine für krebs therapie
CY1106289T1 (el) Χρηση αναστολεων υποδοχεος προγεστepονης για τη θepαπευτικη αντιμετωπιση του καρκινου του μαστου που ειναι ανθεκτικος σε στepοειδη
ATE293991T1 (de) VERWENDUNG EINES MIT DEM PEPTID ßELAGIGILTVß ASSOZIIERTEN ENTEROBAKTERIEN-PROTEINS OMPA ZUR BEHANDLUNG VON MELANOMEN
DE60128445D1 (de) Mutiertes cyclin g1 protein
JP2012519670A (ja) 癌を治療するための方法
NO20040174L (no) Fremgangsmate for donorspesifikk krysstilpasning
DE60025332D1 (de) Synthetisches peptid zur störung intrazellulärer signale